ArticleJournal of experimental & clinical cancer research : CR2020

ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia.

Doh Yu Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.